Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Monroe Capital Sponsors Thunder Bridge Acquisition, Ltd.
-
Reata Pharma (RETA) Announces 3M Share Proposed Public Offering of Class A Common Stock
-
Reata Pharmaceuticals, Inc. Announces Proposed Public Offering of Class A Common Stock
-
Cantor Fitzgerald Starts Kindred Biosciences (KIN) at Buy
-
Endo International plc (ENDP) PT Raised to $12 at Cantor Fitzgerald
-
Timothy Swift Leaves Cantor Fitzgerald to Join Viking Energy Group as Executive V.P. & COO
-
Timothy Swift Leaves Cantor Fitzgerald to Join Viking Energy Group as Executive V.P. & COO
-
FinTech Acquisition Corp. II Stockholders Approve Definitive Merger Agreement with Intermex Holdings II, Inc.
-
LifePoint Health (LPNT) Buyout Could Boost Hospitals Valuations - Cantor Fitzgerald
-
Exponent (EXPO) PT Raised to $56 at Cantor Fitzgerald
-
Zynerba Pharma (ZYNE) Prices 4.06M Offering of Common Stock at $8/Sh
-
Zynerba Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Cerus (CERS) PT Raised to $9 at Cantor Fitzgerald Following Investor Meetings
-
Intuitive Surgical (ISRG) Has Plenty of Room To Run - Cantor Fitzgerald
-
Zynerba Pharma (ZYNE) Announces Proposed Common Share Offering
-
Zynerba Pharmaceuticals (ZYNE) Plans Public Offering of Common Stock
-
Zynerba Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Zynerba Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Form 13F-HR CANTOR FITZGERALD INVEST For: Jun 30
-
PlacementTracker Publishes First Half 2018 PIPE Market League Tables
-
Heron Therapeutics (HRTX) PT Raised to $50 at Cantor Fitzgerald
-
Evolus (EOLS) Prices Prices 4M Share Common Offering at $20/Sh
-
Evolus, Inc. Announces Pricing of Public Offering of Common Stock
-
Orchid Island Capital Announces July 2018 Monthly Dividend and June 30, 2018 RMBS Portfolio Characteristics
-
Ra Medical Systems Files Registration Statement for Proposed Initial Public Offering
-
Fed's Powell: Years of strong jobs, low inflation still ahead
-
Dollar firms after Fed chair's upbeat remarks, global stocks gain
-
Trilogy Metals Reports Second Quarter Fiscal 2018 Financial Results
-
Evolus (EOLS) Announces Proposed 5M Share Common Offering
-
Evolus, Inc. Announces Proposed Public Offering of Common Stock
-
SELLAS Life Sciences Announces Closing of $24.2 Million Public Offering
-
Exotix Capital hires executives to expand fixed income presence
-
Mod-pac Corp (MPAC) Announces Merger with U.S. Well Services LLC
-
Matlin & Partners Acquisition Corporation and U.S. Well Services, LLC Enter Business Combination
-
Thunder Bridge Acquisition, Ltd. Announces Separate Trading of its Class A Ordinary Shares and Warrants, Commencing July 17, 2018
-
Teva Pharma (TEVA) PT Raised to $25 at Cantor Fitzgerald
-
Spero Therapeutics (SPRO) Prices 3.78M Share Offering at $12.50/Sh
-
Spero Therapeutics Announces Pricing of Securities Offering
-
AcelRx Pharma (ACRX) Prices 7.27M Share Offering at $2.75/Sh
-
AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Pre-Open Movers 07/12: (ZGNX) (GLMD) (CA) Higher; (ZN) (ACRX) (AVGO) Lower (more...)
-
SELLAS Life Sciences (SLS) Prices Upsized $24.2 Million Public Offering of Common Stock, Warrants
-
SELLAS Life Sciences Announces Pricing of Upsized $24.2 Million Public Offering
-
Cantor Raises Biohaven (BHVN) PT To $50 After CEO and CFO Meetings
-
After-Hours Stock Movers 7/11: (GLMD) (CA) (WFT) Higher; (ZN) (MYOV) (AVGO) Lower (more...)
-
AcelRx Pharma (ACRX) to Offer Common Stock
-
AcelRx Pharmaceuticals Announces Commencement of Public Offering of Common Stock
-
Cantor Fitzgerald Starts Galmed Pharmaceuticals (GLMD) at Overweight
-
The Ensign Group Inc. (ENSG) PT Raised to $42 at Cantor Fitzgerald
-
Spero Therapeutics (SPRO) Commences 4.5M Common Stock Offering


